Citigroup
NMRD

Citigroup’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Citigroup’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-491
Closed -$4K – 6483
2021
Q1 		$4K Sell
491
-900
-65% -$5.96K ﹤0.01% 5966
2020
Q4 		$5K Buy
1,391
+1,036
+292% +$4K ﹤0.01% 7124
2020
Q3 		$1K Sell
355
-570
-62% -$3.33K ﹤0.01% 7402
2020
Q2 		$9K Buy
+925
New +$6.6K ﹤0.01% 7112

Other funds holding NMRD

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Citigroup's NMRD Position: Q2 2021 in Review

Citigroup sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q2 2021, closing a stake of 491 shares — an estimated $4K sold.

Citigroup first reported a position in NMRD in Q2 2020 and held it in 4 quarters. The position peaked at $9K in Q2 2020. 29 funds tracked by Wall St. Rank hold NMRD as of Q2 2021.

  • Citigroup reported no remaining Nemaura Medical, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Citigroup sold 491 Nemaura Medical, Inc. Common Stock shares in Q2 2021, an estimated $4K.
  • Citigroup first reported a position in Nemaura Medical, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • Citigroup's Nemaura Medical, Inc. Common Stock position peaked at $9K in Q2 2020.
  • 29 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q2 2021.

Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.